Tianlong Introduces Coxsackie A6/A10 Nucleic Acid Detection Kit
By LabMedica International staff writers Posted on 02 Aug 2022 |
Hand, foot, and mouth disease (HFMD) is an infectious disease caused by enteroviruses and is characterized by fever and vesicular eruptions on the hands feet and mouth. There are more than 20 kinds of enteroviruses that cause HFMD. Among them, the enterovirus 71 and Coxsackie A 16 are the most common pathogens. However, in recent years, non-EV71 and non-CA16 enteroviruses have also become important HFMD causing pathogens, among which the Coxsackievirus group A Type 6 (CA) and Coxsackievirus Group A Type 10 (CA10) are important pathogens. Now, a newly-launched nucleic acid detection kit can assist in the diagnosis and treatment of Coxsackie A6/A10 virus infection.
Tianlong Science and Technology (Shaanxi, China) has introduced the Coxsackie A6/A10 Nucleic Acid Detection Kit for the qualitative detection of Coxsackie A6/A10 Virus nucleic acid. The kit enables the detection and differentiation of Coxsackie A6/A10, the important HFMD causing pathogen, using the Real Time Reverse Transcription Polymerase Chain Reaction (Real-time RT-PCR) method. Its innovative 3-in-1 tube PCR with reaction solution, primers and PCR enzymes in one tube, minimizes the time required for sample addition and enables PCR detection within 40 minutes. The Coxsackie A6/A10 Nucleic Acid Detection Kit is CE marked, making it accessible to more countries.
Related Links:
Tianlong Science and Technology
Latest Molecular Diagnostics News
- Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans
- Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset
- Blood Test Could Detect HPV-Associated Cancers 10 Years before Clinical Diagnosis
- Low-Cost Point-Of-Care Diagnostic to Expand Access to STI Testing
- 18-Gene Urine Test for Prostate Cancer to Help Avoid Unnecessary Biopsies
- Urine-Based Test Detects Head and Neck Cancer
- Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer
- Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer
- Simple PCR Assay Accurately Differentiates Between Small Cell Lung Cancer Subtypes
- Revolutionary T-Cell Analysis Approach Enables Cancer Early Detection
- Single Genetic Test to Accelerate Diagnoses for Rare Developmental Disorders
- Upgraded Syndromic Testing Analyzer Enables Remote Test Results Access
- Respiratory and Throat Infection PCR Test Detects Multiple Pathogens with Overlapping Symptoms
- Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis
- First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety
- Fluid Biomarker Test Detects Neurodegenerative Diseases Before Symptoms Appear